Simplex Trading, LLC Amicus Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 20,250 shares of FOLD stock, worth $196,020. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,250

Previous 74,595 72.85%

Holding current value

$196,020

Previous $739,000 70.77%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$9.55 - $12.09 $518,994 - $657,031	-54,345 Reduced 72.85%	20,250 $216,000
Q2 2024 Jul 25, 2024	BUY	$9.04 - $11.75 $448,474 - $582,917	49,610 Added 198.56%	74,595 $739,000
Q1 2024 Apr 25, 2024	SELL	$11.43 - $14.24 $2.59 Million - $3.23 Million	-227,004 Reduced 90.08%	24,985 $294,000
Q4 2023 Feb 02, 2024	BUY	$9.97 - $14.52 $2.2 Million - $3.2 Million	220,670 Added 704.59%	251,989 $3.58 Million
Q3 2023 Nov 01, 2023	BUY	$11.78 - $13.86 $368,937 - $434,081	31,319 New	31,319 $380,000
Q3 2022 Nov 04, 2022	BUY	$9.82 - $12.75 $121,532 - $157,794	12,376 New	12,376 $129,000
Q2 2022 Aug 03, 2022	SELL	$6.23 - $11.12 $11,139 - $19,882	-1,788 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$7.89 - $12.48 $318,235 - $503,368	-40,334 Reduced 95.76%	1,788 $16,000
Q3 2021 Oct 28, 2021	BUY	$8.74 - $11.84 $108,813 - $147,408	12,450 Added 41.96%	42,122 $416,000
Q2 2021 Aug 12, 2021	SELL	$8.71 - $10.72 $1.09 Million - $1.34 Million	-125,105 Reduced 80.83%	29,672 $286,000
Q1 2021 Apr 26, 2021	BUY	$9.2 - $23.86 $1.04 Million - $2.7 Million	113,246 Added 272.68%	154,777 $1.53 Million
Q4 2020 Feb 02, 2021	BUY	$13.47 - $24.89 $120,192 - $222,093	8,923 Added 27.36%	41,531 $958,000
Q3 2020 Oct 14, 2020	SELL	$12.89 - $15.89 $714,943 - $881,338	-55,465 Reduced 62.98%	32,608 $460,000
Q2 2020 Jul 13, 2020	BUY	$8.86 - $15.69 $582,057 - $1.03 Million	65,695 Added 293.57%	88,073 $1.33 Million
Q1 2020 Apr 29, 2020	BUY	$6.63 - $11.16 $77,610 - $130,638	11,706 Added 109.69%	22,378 $206,000
Q4 2019 Feb 05, 2020	BUY	$7.48 - $10.75 $22,200 - $31,906	2,968 Added 38.53%	10,672 $103,000
Q3 2019 Oct 15, 2019	SELL	$8.02 - $13.25 $174,715 - $288,651	-21,785 Reduced 73.88%	7,704 $61,000
Q2 2019 Jul 26, 2019	BUY	$10.96 - $14.4 $323,199 - $424,641	29,489 New	29,489 $368,000
Q1 2019 Apr 18, 2019	SELL	$10.04 - $13.92 $95,620 - $132,574	-9,524 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$8.38 - $13.44 $68,079 - $109,186	8,124 Added 580.29%	9,524 $91,000
Q3 2018 Oct 23, 2018	BUY	$11.6 - $16.54 $16,240 - $23,156	1,400 New	1,400 $16,000
Q4 2017 Jan 10, 2018	SELL	$12.51 - $16.24 $504,603 - $655,056	-40,336 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$11.74 - $15.78 $473,544 - $636,502	40,336	40,336 $608,000

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.72B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Amicus Therapeutics, Inc. Transaction History